Picture of IntegraGen SA logo

ALINT — IntegraGen SA Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for IntegraGen SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2009
December 31st
2025
December 31st
Period Length:12 M12 M
Source:Interim ReportARS
Standards:
FAS
FAS
Status:FinalFinal
Net Income/Starting Line-2.6-2.66
Depreciation
Non-Cash Items-0.0920.379
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.7730.71
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.76-1.58
Capital Expenditures-0.03-0.002
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0580.043
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities0.0280.04
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.510.749
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.771-0.787